Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension

Author:

Silver Lewis H.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference9 articles.

1. Brinzolamide (AL-4862) suspension is a new topically active carbonic anhydrase inhibitor in the Dutch-belted rabbit and cynomolgus monkey. ARVO abstracts;Dean;Invest Ophthalmol Vis Sci,1997

2. Carbonic anhydrase isoenzymes CA I and CA II in the human eye;Wistrand;Invest Ophthalmol Vis Sci,1986

3. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension;Strahlman;Am J Ophthalmol,1996

4. The ocular comfort of TID-dosed brinzolamide 1.0% compared to TID-dosed dorzolamide 2.0% in patients with primary open-angle glaucoma or ocular hypertension;Stewart;Invest Ophthalmol Vis Sci,1997

5. A triple-masked, primary therapy study of the efficacy and safety of BID and TID-dosed brinzolamide 1.0% compared to TID-dosed dorzolamide 2.0% and BID-dosed timolol 0.5%;Camras;Invest Ophthalmol Vis Sci,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3